The Use of Extracorporeal Membrane Oxygenation During Acute Chest Crisis in an Adult Sickle Cell Disease Patient: Identification of Pearls and Pitfalls

Abstract

Get full access to this article

View all access options for this article.

References

Kuo

KW.

Cornell

TT.

Shanley

TP.

Odetola

FO.

Annich

. The use of extracorporeal membrane oxygenation in pediatric patients with sickle cell disease. Perfusion. 2013;28(5):424-432.doi:10.1177/0267659113485873

http://www.ncbi.nlm.nih.gov/pubmed/23630196

Sewaralthahab

SS.

Menaker

Law

. Successful use of veno-venous extracorporeal membrane oxygenation in an adult patient with sickle cell anemia and severe acute chest syndrome. Hemoglobin. 2018;42(1):65-67.doi:10.1080/03630269.2018.1450755

http://www.ncbi.nlm.nih.gov/pubmed/29633667

Peek

GJ.

Mugford

Tiruvoipati

et al. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet. 2009;374(9698):1351-1363.doi:10.1016/S0140-6736(09)61069-2

http://www.ncbi.nlm.nih.gov/pubmed/19762075

American Society of Hematology . State of Sickle Cell Disease. http://www.scdcoalition.org/pdfs/ASH State of Sickle Cell Disease 2016 Report.pdf